Veterinary Medicine Information website

BYKAHEPAR ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΣΚΥΛΟΥΣ ΚΑΙ ΓΑΤΕΣ

Authorised
  • Clanobutin sodium
Download as PDF

Product identification

Medicine name:
BYKAHEPAR ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΣΚΥΛΟΥΣ ΚΑΙ ΓΑΤΕΣ
Active substance:
  • Clanobutin sodium
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Clanobutin sodium
    106.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA16QA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas M.A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Trirx Segre
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 26791/08-04-2013/K-0009901
Date of authorisation status change: